MIMEDX GROUP INC
For the period ended Mar 31, 2025. Filed Apr 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 30, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
There have been no material changes to the Company’s risk factors included in its 2024 Form 10-K.
(a) None.
(b) None.
(c) The following table sets forth information regarding the purchases of the Company’s equity securities made by or on behalf of the Company or any affiliated purchases (as defined in Exchange Act Rule 10b-18) during the three month period ended March 31, 2025:
| Total number of shares purchased1 | Average price paid per share | Total number of shares purchased under publicly announced plan | Approximate dollar value of shares that may yet be purchased under plans or programs | |
|---|---|---|---|---|
| January 1 - January 31, 2025 | — | $— | — | $— |
| February 1 - February 28, 2025 | 186,242 | 8.30 | — | — |
| March 1 - March 31, 2025 | 115,059 | 7.93 | — | — |
| Total for the quarter | 301,301 | $8.16 | $— | $— |
(1) Reflect net settlement of shares by the Company upon vesting of employee restricted stock units in order to satisfy tax withholding obligations.
Not applicable.
Not applicable.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.